References
Original article
Neelapu, S. S. et al. Axicabtagene ciloleucel as first-line therapy in high-risk large B-cell lymphoma: the phase 2 ZUMA-12 trial. Nat. Med. https://doi.org/10.1038/s41591-022-01731-4 (2022)
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Killock, D. CAR T cells show promise in the frontline for high-risk LBCL. Nat Rev Clin Oncol 19, 283 (2022). https://doi.org/10.1038/s41571-022-00628-y
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41571-022-00628-y
- Springer Nature Limited